CAS 54404-06-7: 3-oxo-2,3-dihydropyridazine-4-carboxylic acid

3-Oxo-2,3-dihydropyridazine-4-carboxylic acid (3ODPCA) is a molecule that is used to treat endometriosis. It has been shown to have anti-inflammatory properties, which may be due to its ability to inhibit the production of prostaglandin E2 and nitric oxide. 3ODPCA binds to DNA with high affinity and interferes with transcription by inhibiting the binding of RNA polymerase II and III, preventing the synthesis of mRNA. This drug also inhibits protein synthesis in cells by inhibiting ribosome translocation on mRNA. 3ODPCA has been shown to be an effective treatment for endometriosis in rats and mice models.